This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Nov 25;363(22):2171; author reply 2173-4.

doi: 10.1056/NEJMc1009236.

Retinopathy progression in type 2 diabetes

Hiroyuki Morita, Ryozo Nagai

PMID: 21105810
DOI: 10.1056/NEJMc1009236

Comment

Retinopathy progression in type 2 diabetes

Hiroyuki Morita et al. N Engl J Med. 2010.

. 2010 Nov 25;363(22):2171; author reply 2173-4.

doi: 10.1056/NEJMc1009236.

Authors

Hiroyuki Morita, Ryozo Nagai

PMID: 21105810
DOI: 10.1056/NEJMc1009236

No abstract available

PubMed Disclaimer

Comment on

Effects of medical therapies on retinopathy progression in type 2 diabetes.
ACCORD Study Group; ACCORD Eye Study Group; Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. ACCORD Study Group, et al. N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29. N Engl J Med. 2010. PMID: 20587587 Free PMC article. Clinical Trial.

Similar articles

Reduction in risk of progression of diabetic retinopathy.
Klein BE. Klein BE. N Engl J Med. 2010 Jul 15;363(3):287-8. doi: 10.1056/NEJMe1005667. Epub 2010 Jun 29. N Engl J Med. 2010. PMID: 20587586 No abstract available.
Retinopathy progression in type 2 diabetes.
Baum SJ. Baum SJ. N Engl J Med. 2010 Nov 25;363(22):2172; author reply 2173-4. doi: 10.1056/NEJMc1009236. N Engl J Med. 2010. PMID: 21105808 No abstract available.
Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes.
Singh RP, Gans R, Kashyap SR, Bedi R, Wolski K, Brethauer SA, Nissen SE, Bhatt DL, Schauer P. Singh RP, et al. Diabetes Care. 2015 Mar;38(3):e32-3. doi: 10.2337/dc14-2035. Diabetes Care. 2015. PMID: 25715418 Free PMC article. Clinical Trial. No abstract available.
[Prevention of diabetic retinopathy in type 2 diabetic patients].
Shiba T. Shiba T. Nihon Rinsho. 2002 Oct;60 Suppl 10:167-72. Nihon Rinsho. 2002. PMID: 12430224 Review. Japanese. No abstract available.
Update on systemic management of diabetes.
Masharani U, Rushakoff RJ. Masharani U, et al. Int Ophthalmol Clin. 2009 Spring;49(2):13-33. doi: 10.1097/IIO.0b013e31819fd36b. Int Ophthalmol Clin. 2009. PMID: 19349784 Review. No abstract available.

See all similar articles

Cited by

Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus.
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B, Jiang Q. Liu JY, et al. Cell Death Dis. 2014 Oct 30;5(10):e1506. doi: 10.1038/cddis.2014.466. Cell Death Dis. 2014. PMID: 25356875 Free PMC article.
Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.
Tang HC, Chen CY. Tang HC, et al. Evid Based Complement Alternat Med. 2014;2014:385120. doi: 10.1155/2014/385120. Epub 2014 May 6. Evid Based Complement Alternat Med. 2014. PMID: 24891870 Free PMC article.
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.
Noonan JE, Jenkins AJ, Ma JX, Keech AC, Wang JJ, Lamoureux EL. Noonan JE, et al. Diabetes. 2013 Dec;62(12):3968-75. doi: 10.2337/db13-0800. Diabetes. 2013. PMID: 24264394 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information